Meta tags:

Headings (most frequently used words):

series, approach, to, cancer, our, spotlight, avacta, academy, episode, pre, cision, fap, activated, drug, delivery, platform, challenging, the, current, unique, treating, vision, latest, news, research, development, 15,

Text of the page (most frequently used words):
the (16), our (10), avacta (8), #cancer (7), tumor (6), #series (5), drug (5), therapeutics (4), watch (4), use (3), that (3), you (3), spotlight (3), academy (3), existing (3), pre (3), cision (3), technology (3), approach (3), fap (3), site (2), are (2), with (2), contact (2), terms (2), read (2), more (2), research (2), development (2), episode (2), news (2), videos (2), from (2), while (2), patient (2), and (2), not (2), cells (2), active (2), bloodstream (2), peptide (2), only (2), found (2), cookies, ensure, give, best, experience, website, continue, this, will, assume, happy, 2026, registered, company, 06605196, linkedin, twitter, email, cohesion, bureau, investor, enquiries, 3911, 0353, scale, space, white, city, imperial, college, campus, wood, lane, london, w12, 7rz, group, plc, corporate, responsibility, intellectual, property, privacy, policy, conditions, latest, conquer, therapies, preserving, vitality, healing, vision, future, treatment, means, having, choose, between, eliminating, safeguarding, wellness, designed, concentrate, maintaining, inactive, enabled, unique, treating, innovative, links, inactivate, can, removed, enzyme, scientific, leverages, drugs, delivered, precisely, using, proprietary, challenging, current, release, triggered, protein, supporting, silent, activated, delivery, platform, your, browser, does, support, video, tag, careers, investors, pipeline, science, about, search, for, homepage,

Text of the page (random words):
homepage avacta therapeutics search for avacta therapeutics about our science pipeline news investors careers contact your browser does not support the video tag pre cision fap activated drug delivery platform silent in the bloodstream active in the tumor drug release is triggered only at the tumor site by fap a protein found in tumor supporting cells challenging the current approach to cancer our scientific approach leverages existing cancer drugs that are delivered precisely to the tumor using our proprietary technology our innovative technology links a peptide to an existing cancer drug to inactivate it the peptide can only be removed by an enzyme found in the tumor fap our unique approach to treating cancer our pre cision technology is designed to concentrate the active drug in the tumor while maintaining the inactive pre cision enabled drug in the bloodstream the future of cancer treatment means not having to choose between eliminating cancer cells and safeguarding patient wellness our vision to conquer cancer with existing therapies while preserving patient vitality and healing r d spotlight series watch the videos from our research development spotlight series watch avacta academy series watch the videos from our avacta academy series watch latest news avacta academy episode 4 read more research development spotlight series episode 15 read more avacta therapeutics terms of use terms conditions privacy policy intellectual property corporate responsibility contact us avacta group plc scale space white city imperial college campus 58 wood lane london w12 7rz 44 0 20 3911 0353 investor enquiries cohesion bureau email twitter linkedin 2026 avacta therapeutics registered company no 06605196 we use cookies to ensure that we give you the best experience on our website if you continue to use this site we will assume that you are happy with it ok